SuperSonic Imagine Showcases Clinical Innovations During

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
SuperSonic Imagine Showcases Clinical Innovations During the European Congress of Radiology

AIX-EN-PROVENCE, FRANCE--(Marketwired - Mar 1, 2016) - SuperSonic Imagine ( EURONEXT PARIS : SSI ) (FR0010526814), the highly innovative ultrasound company, announced today its participation in the European Congress of Radiology (ECR) March 2 - 6, in Vienna, Austria, to demonstrate the clinical benefits of real-time ShearWave™ Elastography (SWE™) in assessing major diseases such as chronic liver disease and cancer of the breast, prostate and thyroid as well as in the domain of musculoskeletal imaging. The Company is also featuring two new innovations during the Congress, which they will be demonstrating on the show floor ( booth #4 in Exhibit Hall A) .

SuperSonic Imagine will showcase its new solution for microvascular visualization, Angio PL.U.S. -- Planewave UltraSensitive™ imaging. Angio PL.U.S. is a significant advancement in Color Doppler Imaging. Conventional Doppler is limited in its ability to show microvascular slow flow. Angio PL.U.S. provides a new level of microvascular imaging through significantly improved color sensitivity and spatial resolution while maintaining exceptional 2D imaging. It increases the detail of real-time flow information available during ultrasound diagnostic exams. This information is instrumental in helping the diagnosis of cancerous tissues in areas such as the liver, lymph nodes and thyroid as well as musculoskeletal pathologies such as inflammation in tendons. Angio PL.U.S. leverages SuperSonic Imagine's previous innovation, UltraFast™ Doppler, providing an advanced solution for vascular evaluation.

Also during ECR, SuperSonic Imagine will be highlighting the clinical benefits a new SuperEndocavity™ Volumetric transducer, the unique endo transducer on the market that enables 2D AND 3D imaging for B-Mode, Color modes and SWE. This information is very useful in the diagnosis and monitoring of prostate cancer as well as for gynecologic and obstetrics applications.

Both of these latest innovations can be found as part of SuperSonic Imagine's platform Aixplorer ® , the only ultrasound system available that provides SWE in real-time. SWE is a quick, non-invasive exam that provides color coded maps and quantitative measurement of tissue stiffness. This information is used by physicians to help identify potentially malignant or other diseased tissue. As of today, over 300 peer-reviewed articles have demonstrated the clinical benefits of SWE in a wide range of clinical applications.

"Clinicians are eager for imaging advances and new tools to help identify and diagnose suspicious lesions while avoiding unnecessary imaging or biopsies," said Jacques Souquet, SuperSonic Imagine's Chief Innovation Officer and Founder. "Angio PL.U.S. and our new 3D endo transducer combined with our existing innovations, SWE and UltraFast™ Doppler, represent significant advancements to the arsenal of non-invasive diagnostic tools for cancer or other major diseases."

"From my experience, the new 3D endocavity transducer brings significant improvement to prostate imaging with ultrasound and could provide a true alternative to multi-parametric MRI imaging currently used for prostate cancer," said Pr. Jean-Michel Correas, Vice Chairman of the Adult Radiology Department at Necker University Hospital, Paris, France. "With 3D ShearWave Elastography, for the first time, we are able to clearly identify and target suspicious regions of the prostate with an ultrasound based technique." 

During the ECR (March 2, 12:30 - 1:30pm, Room N), SSI will host a symposium "UltraFast Imaging: A New Paradigm for Ultrasound Diagnosis - How innovations derived from UltraFast Imaging are improving diagnosis and patient management across diseases." Participants will include Dr. Maja Thiele, Prof. FKW. Schafer, Prof. JM. Correas, and Mr. Mickael Tanter. For additional information or to register can be found HERE .

Additional information about ECR can be found here . The Company will be exhibiting at booth #4 in Exhibit Hall A and will be hosting live demonstrations at the booth throughout the meeting.

About SuperSonic Imagine

Founded in 2005 and based in Aix-en-Provence (France), SuperSonic Imagine is a company specializing in medical imaging. The company designs, develops and markets a revolutionary ultrasound system, Aixplorer®, with an UltraFast™ platform that can acquire images 200 times faster than conventional ultrasound systems. Aixplorer is the only system that can image two types of waves: ultrasound waves ensure excellent image quality and shear waves, which allow physicians to visualize and analyze the stiffness of tissue in a real-time, reliable, reproducible and non-invasive manner. This innovation, ShearWave™ Elastography, significantly improves the detection and characterization of numerous pathologies in several applications including breast, thyroid, liver and prostate. SuperSonic Imagine has been granted regulatory clearances for the commercialization of Aixplorer in the main global markets. Over the past years, SuperSonic Imagine enjoyed the backing of several prestigious investors, among which Auriga Partners, Edmond de Rothschild Investment Partners, Bpifrance, Omnes Capital and NBGI.

For more information about SuperSonic Imagine, please go to www.supersonicimagine.com .

SuperSonic Imagine Corporate Bernard Doorenbos Email Contact +33 6 15 66 64 68 SuperSonic Imagine Marketing & Communication Emmanuelle Vella Email Contact +33 4 86 79 03 27 NewCap Investor Relations - EU Pierre Laurent / Florent Alba Email Contact +33 1 44 71 98 55 Pascale Communication Media Relations - US Amy Phillips Email Contact +1 412 327 9499

Scroll down for more posts ▼

Top 10 Most Recent News Articles

FAMID's Six-Month IVDR Win Opens Europe's Market Door

Updated Category News Views 25

A six-month regulatory sprint is the sort of result that makes a crowded diagnostics field pause and squint. DNV has issued an IVDR certificate to FAMID Biomedical Technology for its E7 Oncoprotein Rapid Test Kit, a Class C in vitro diagnostic intended to aid diagnosis of cervical epithelial cell lesions through detection of HPV E7 oncoprotein in cervical cell samples....

Continue Reading
A Parish Memoir That Sends Its Proceeds Back Home

Updated Category News Views 142

Some books arrive with a thunderclap; this one shows up carrying a folding chair, a prayer book, and a memory that refuses to leave. You Give Them Something to Eat, the new memoir from Fr. Michael J Rieder, is built from more than a hundred short chapters rather than one grand, polished life story. That choice fits the material. Parish life is rarely a clean parade of...

Continue Reading
Litmus Gets $475 Million as Music Rights Mature Further

Updated Category News Views 115

Music royalties just got another serious pile of institutional money, and Litmus is holding the shovel. The company announced roughly $475 million of new capital commitments from Carlyle and investment funds managed by KKR, a notable vote of confidence in a platform that did not even exist before 2022. This is not some celebrity vanity vehicle buying a famous chorus and...

Continue Reading
Vusion Lands a 2,000-Store dm EdgeSense Rollout in Germany

Updated Category News Views 150

A drugstore shelf rarely gets anyone's pulse racing, but 2,000 of them wired into a live digital system is a serious retail deployment. Vusion has expanded its partnership with dm-drogerie markt to roll out its newest EdgeSense platform across about 2,000 German stores over the next three years. This is not a glossy one-store pilot with a ribbon-cutting and a few tablets...

Continue Reading
MIND Takes Its Copilot Security Bet Across Microsoft 365

Updated Category News Views 81

Copilot’s promise gets a lot less charming the minute confidential files start wandering around unchecked. That is the knot MIND is trying to untie with its expanded, generally available integrations across Microsoft Copilot, Microsoft 365, Purview, Teams, SharePoint, OneDrive, Edge and Exchange. The Seattle data-loss-prevention company announced the collaboration on...

Continue Reading
Vertex Extends Genomics Pact With $220M in Potential

Updated Category News Views 177

Eight years is long enough to separate a useful science partner from a glossy slide deck, and Vertex’s decision to add four more years with Genomics deserves attention. This is not a splashy acquisition, nor is it a clean revenue number investors can plug into next quarter’s model. It is a deeper commitment to the slow, expensive, wonderfully unforgiving business of...

Continue Reading
Perform.AI Tests Whether Stores Can Sell to Agents

Updated Category News Views 98

Shopping bots are about to become one more fussy customer standing in the aisle, except this one reads machine-facing files, rejects broken checkout steps, and does not care how pretty the homepage looks. Perform.AI has launched a free UCP and ACP Readiness Checker aimed at online retailers that need to know whether AI agents can find products, purchase them, and follow...

Continue Reading
Nightguards and TMJ Appliances Require Different Calls

Updated Category News Views 115

Two clear plastic devices can invite a costly wrong turn. Dr. Terrance O’Keefe’s explanation, published Nov. 18, 2026, draws a line that patients too often blur: a nightguard protects teeth from grinding, while a TMJ appliance is meant to address joint and muscle strain tied to temporomandibular disorders. They may look alike sitting in a case. Their jobs are not...

Continue Reading
Fidelis Puts $140,000 Behind Statewide Postpartum Care

Updated Category News Views 83

A missed postpartum appointment can look like a small administrative failure until it is not. Fidelis Care’s $140,000 round of Here for Your Health maternal health grants is aimed squarely at that unglamorous but consequential gap: keeping new mothers connected to care after delivery, particularly in underserved New York communities. Small Dollars, Very Specific...

Continue Reading
Specialty Chemicals Need Demand Before Capacity Bets

Updated Category News Views 96

Empty reactor space does not get filled because everybody suddenly loves reshoring. SOCMA's 2027 Contract Manufacturing Outlook makes that stubborn fact hard to dodge: nearly 70% of surveyed respondents expect North American manufacturing activity to rise over the next three years, yet 79.5% say stronger, more predictable customer demand is critical before future...

Continue Reading

Top 5 Most Recently Viewed Articles

New Terminal One Partners with Plaza Premium to Elevate Travel

Updated Category News Views 234

New Terminal One & Plaza Premium Group Collaboration The New Terminal One at JFK International Airport has joined forces with Plaza Premium Group (PPG), a leading name in airport hospitality, to create two state-of-the-art lounges. Together, they aim to transform the travel experience at this vital international hub, covering close to 14,000 square feet and promising...

Continue Reading
Market Update: S&P 500 Fluctuates After Holiday Trading

Updated Category News Views 337

S&P 500 Experiences Mixed Results in Light Trading The recent trading session saw the S&P 500 close on a flat note after a day of ups and downs, all in the backdrop of lower-than-usual trading volumes, a trend typical of the holiday breakout. As of the market close, the S&P 500 had dipped by 0.1%, while the NASDAQ Composite mirrored this decrease. In contrast, the Dow...

Continue Reading
Brand Engagement Network Expands Horizons with Cataneo Acquisition

Updated Category News Views 104

Brand Engagement Network Expands Strategic Capabilities Jackson, Wyo. – brand Engagement Network, Inc. (NASDAQ: BNAI) has recently made headlines by agreeing to acquire a German media technology powerhouse, Cataneo Gmbh. This acquisition not only highlights BEN's commitment to growth but also demonstrates its ambition to transform how brands use AI to engage with their...

Continue Reading
Metagenomi Showcases Advanced Adenine Base Editors for Gene Therapy

Updated Category News Views 195

Introducing Metagenomi's Innovative Adenine Base Editors Metagenomi has unveiled its cutting-edge Adenine Base Editors (ABEs) at a recent event, highlighting their impressive capabilities in genome editing. These novel tools achieved over 95% targetability in gene modification, demonstrating exceptional performance and efficiency. Key Highlights from the Presentation...

Continue Reading
Streamlining IT Procurement: SysAid Launches on AWS Marketplace

Updated Category News Views 49

SysAid Now Accessible via AWS Marketplace SysAid, a leading Enterprise and IT Service Management solution provider, has made an exciting announcement regarding its availability on AWS Marketplace. This curated digital catalog is designed to simplify the process of discovering, procuring, and deploying software solutions. With AWS Marketplace having over 290,000 active...

Continue Reading